United States Parkinson's Disease Treatment Market Report 2017

January 2018 | 114 pages | ID: UB0B96DA8B7EN
QYResearch

Abstracts

In this report, the United States Parkinson's Disease Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Parkinson's Disease Treatment in these regions, from 2012 to 2022 (forecast).

United States Parkinson's Disease Treatment market competition by top manufacturers/players, with Parkinson's Disease Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Teva (Israel)
• Novartis AG (Switzerland)
• GSK (UK)
• AbbVie (US)
• Merck (US)
• Boehringer Ingelheim (Germany)
• Impax Laboratories (US)
• Lundbeck (Denmark)
• UCB (Belgium)
• Valeant Pharmaceuticals (Canada)
• Acadia (US)
• Sun Pharma (India)
• Wockhardt (India)
• Dr. Reddy's (India)
• Intas (India)
• US WorldMeds (US)
• Zydus Cadila (India)
• Cipla (India)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Levodopa/carbidopa
• Dopamine Receptor Agonists
• MAO-Inhibitors
• COMT-inhibitors
• Anticholinergics
• Other Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital Pharmacies
• Retailer Pharmacies
• Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Parkinson's Disease Treatment Market Report 2017

1 PARKINSON'S DISEASE TREATMENT OVERVIEW

1.1 Product Overview and Scope of Parkinson's Disease Treatment
1.2 Classification of Parkinson's Disease Treatment by Product Category
  1.2.1 United States Parkinson's Disease Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Parkinson's Disease Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Levodopa/carbidopa
  1.2.4 Dopamine Receptor Agonists
  1.2.5 MAO-Inhibitors
  1.2.6 COMT-inhibitors
  1.2.7 Anticholinergics
  1.2.8 Other Drugs
1.3 United States Parkinson's Disease Treatment Market by Application/End Users
  1.3.1 United States Parkinson's Disease Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacies
  1.3.3 Retailer Pharmacies
  1.3.4 Online Pharmacies
1.4 United States Parkinson's Disease Treatment Market by Region
  1.4.1 United States Parkinson's Disease Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Parkinson's Disease Treatment Status and Prospect (2012-2022)
  1.4.3 Southwest Parkinson's Disease Treatment Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Parkinson's Disease Treatment Status and Prospect (2012-2022)
  1.4.5 New England Parkinson's Disease Treatment Status and Prospect (2012-2022)
  1.4.6 The South Parkinson's Disease Treatment Status and Prospect (2012-2022)
  1.4.7 The Midwest Parkinson's Disease Treatment Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Parkinson's Disease Treatment (2012-2022)
  1.5.1 United States Parkinson's Disease Treatment Sales and Growth Rate (2012-2022)
  1.5.2 United States Parkinson's Disease Treatment Revenue and Growth Rate (2012-2022)

2 UNITED STATES PARKINSON'S DISEASE TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Parkinson's Disease Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Parkinson's Disease Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Parkinson's Disease Treatment Average Price by Players/Suppliers (2012-2017)
2.4 United States Parkinson's Disease Treatment Market Competitive Situation and Trends
  2.4.1 United States Parkinson's Disease Treatment Market Concentration Rate
  2.4.2 United States Parkinson's Disease Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Parkinson's Disease Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PARKINSON'S DISEASE TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Parkinson's Disease Treatment Sales and Market Share by Region (2012-2017)
3.2 United States Parkinson's Disease Treatment Revenue and Market Share by Region (2012-2017)
3.3 United States Parkinson's Disease Treatment Price by Region (2012-2017)

4 UNITED STATES PARKINSON'S DISEASE TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Parkinson's Disease Treatment Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Parkinson's Disease Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Parkinson's Disease Treatment Price by Type (2012-2017)
4.4 United States Parkinson's Disease Treatment Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PARKINSON'S DISEASE TREATMENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Parkinson's Disease Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Parkinson's Disease Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PARKINSON'S DISEASE TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Teva (Israel)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Parkinson's Disease Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Teva (Israel) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis AG (Switzerland)
  6.2.2 Parkinson's Disease Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis AG (Switzerland) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GSK (UK)
  6.3.2 Parkinson's Disease Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GSK (UK) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 AbbVie (US)
  6.4.2 Parkinson's Disease Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 AbbVie (US) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merck (US)
  6.5.2 Parkinson's Disease Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck (US) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Boehringer Ingelheim (Germany)
  6.6.2 Parkinson's Disease Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Impax Laboratories (US)
  6.7.2 Parkinson's Disease Treatment Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Impax Laboratories (US) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Lundbeck (Denmark)
  6.8.2 Parkinson's Disease Treatment Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Lundbeck (Denmark) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 UCB (Belgium)
  6.9.2 Parkinson's Disease Treatment Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 UCB (Belgium) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Valeant Pharmaceuticals (Canada)
  6.10.2 Parkinson's Disease Treatment Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Acadia (US)
6.12 Sun Pharma (India)
6.13 Wockhardt (India)
6.14 Dr. Reddy's (India)
6.15 Intas (India)
6.16 US WorldMeds (US)
6.17 Zydus Cadila (India)
6.18 Cipla (India)

7 PARKINSON'S DISEASE TREATMENT MANUFACTURING COST ANALYSIS

7.1 Parkinson's Disease Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Parkinson's Disease Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Parkinson's Disease Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Parkinson's Disease Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PARKINSON'S DISEASE TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Parkinson's Disease Treatment Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Parkinson's Disease Treatment Sales Volume Forecast by Type (2017-2022)
11.3 United States Parkinson's Disease Treatment Sales Volume Forecast by Application (2017-2022)
11.4 United States Parkinson's Disease Treatment Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Parkinson's Disease Treatment
Figure United States Parkinson's Disease Treatment Market Size (K Units) by Type (2012-2022)
Figure United States Parkinson's Disease Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Levodopa/carbidopa Product Picture
Figure Dopamine Receptor Agonists Product Picture
Figure MAO-Inhibitors Product Picture
Figure COMT-inhibitors Product Picture
Figure Anticholinergics Product Picture
Figure Other Drugs Product Picture
Figure United States Parkinson's Disease Treatment Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Parkinson's Disease Treatment by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retailer Pharmacies Examples
Table Key Downstream Customer in Retailer Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure United States Parkinson's Disease Treatment Market Size (Million USD) by Region (2012-2022)
Figure The West Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2022)
Figure United States Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Parkinson's Disease Treatment Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Parkinson's Disease Treatment Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Parkinson's Disease Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Parkinson's Disease Treatment Sales Share by Players/Suppliers
Figure 2017 United States Parkinson's Disease Treatment Sales Share by Players/Suppliers
Figure United States Parkinson's Disease Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Parkinson's Disease Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Parkinson's Disease Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Parkinson's Disease Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Parkinson's Disease Treatment Revenue Share by Players/Suppliers
Table United States Market Parkinson's Disease Treatment Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Parkinson's Disease Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Parkinson's Disease Treatment Market Share of Top 3 Players/Suppliers
Figure United States Parkinson's Disease Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Parkinson's Disease Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Parkinson's Disease Treatment Product Category
Table United States Parkinson's Disease Treatment Sales (K Units) by Region (2012-2017)
Table United States Parkinson's Disease Treatment Sales Share by Region (2012-2017)
Figure United States Parkinson's Disease Treatment Sales Share by Region (2012-2017)
Figure United States Parkinson's Disease Treatment Sales Market Share by Region in 2016
Table United States Parkinson's Disease Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Parkinson's Disease Treatment Revenue Share by Region (2012-2017)
Figure United States Parkinson's Disease Treatment Revenue Market Share by Region (2012-2017)
Figure United States Parkinson's Disease Treatment Revenue Market Share by Region in 2016
Table United States Parkinson's Disease Treatment Price (USD/Unit) by Region (2012-2017)
Table United States Parkinson's Disease Treatment Sales (K Units) by Type (2012-2017)
Table United States Parkinson's Disease Treatment Sales Share by Type (2012-2017)
Figure United States Parkinson's Disease Treatment Sales Share by Type (2012-2017)
Figure United States Parkinson's Disease Treatment Sales Market Share by Type in 2016
Table United States Parkinson's Disease Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Parkinson's Disease Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Treatment by Type (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Treatment by Type in 2016
Table United States Parkinson's Disease Treatment Price (USD/Unit) by Types (2012-2017)
Figure United States Parkinson's Disease Treatment Sales Growth Rate by Type (2012-2017)
Table United States Parkinson's Disease Treatment Sales (K Units) by Application (2012-2017)
Table United States Parkinson's Disease Treatment Sales Market Share by Application (2012-2017)
Figure United States Parkinson's Disease Treatment Sales Market Share by Application (2012-2017)
Figure United States Parkinson's Disease Treatment Sales Market Share by Application in 2016
Table United States Parkinson's Disease Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Parkinson's Disease Treatment Sales Growth Rate by Application (2012-2017)
Table Teva (Israel) Basic Information List
Table Teva (Israel) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva (Israel) Parkinson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Teva (Israel) Parkinson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Teva (Israel) Parkinson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table GSK (UK) Basic Information List
Table GSK (UK) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK (UK) Parkinson's Disease Treatment Sales Growth Rate (2012-2017)
Figure GSK (UK) Parkinson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure GSK (UK) Parkinson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table AbbVie (US) Basic Information List
Table AbbVie (US) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie (US) Parkinson's Disease Treatment Sales Growth Rate (2012-2017)
Figure AbbVie (US) Parkinson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure AbbVie (US) Parkinson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Merck (US) Basic Information List
Table Merck (US) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck (US) Parkinson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Merck (US) Parkinson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Merck (US) Parkinson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Impax Laboratories (US) Basic Information List
Table Impax Laboratories (US) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Lundbeck (Denmark) Basic Information List
Table Lundbeck (Denmark) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table UCB (Belgium) Basic Information List
Table UCB (Belgium) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure UCB (Belgium) Parkinson's Disease Treatment Sales Growth Rate (2012-2017)
Figure UCB (Belgium) Parkinson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure UCB (Belgium) Parkinson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Valeant Pharmaceuticals (Canada) Basic Information List
Table Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Acadia (US) Basic Information List
Table Sun Pharma (India) Basic Information List
Table Wockhardt (India) Basic Information List
Table Dr. Reddy's (India) Basic Information List
Table Intas (India) Basic Information List
Table US WorldMeds (US) Basic Information List
Table Zydus Cadila (India) Basic Information List
Table Cipla (India) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease Treatment
Figure Manufacturing Process Analysis of Parkinson's Disease Treatment
Figure Parkinson's Disease Treatment Industrial Chain Analysis
Table Raw Materials Sources of Parkinson's Disease Treatment Major Players/Suppliers in 2016
Table Major Buyers of Parkinson's Disease Treatment
Table Distributors/Traders List
Figure United States Parkinson's Disease Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Parkinson's Disease Treatment Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Parkinson's Disease Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Parkinson's Disease Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Parkinson's Disease Treatment Sales Volume (K Units) Forecast by Type in 2022
Table United States Parkinson's Disease Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Parkinson's Disease Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Parkinson's Disease Treatment Sales Volume (K Units) Forecast by Application in 2022
Table United States Parkinson's Disease Treatment Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Parkinson's Disease Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Parkinson's Disease Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Parkinson's Disease Treatment Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources